Voyager Acquisition, a blank check company targeting the healthcare sector, filed on Tuesday with the SEC to raise up to $261 million in an initial public offering.
The Houston, TX-based company plans to raise $261 million by offering 26.1 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. At the proposed deal size, Voyager Acquisition would command a market value of $326 million.
The company is led by CEO and Director Adeel Rouf, a former Investment Professional at Cohen and Company Asset Management, and Chairman Warren Hosseinion, who currently serves as President of Nutex Health and previously co-founded Apollo Medical Holdings. It plans to target the healthcare and healthcare-related industries, focusing on businesses with enterprise values between $160 million and $2 billion.
Rouf has held various roles with several other SPACs, including currently serving as COO of Northern Revival Acquisition (NRAC; trading suspended since February 2024), which has a pending merger agreement with Australia-based agtech Braiin. He also previously served as CFO of Founder SPAC, which merged with Rubicon Technologies (BMV: RBT; -97% from $10 offer price) in 2022.
Voyager Acquisition was founded in 2023 and plans to list on the Nasdaq under the symbol VACHU. Cantor Fitzgerald is the sole bookrunner on the deal.
